Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
44,092,800
-
Shares change
-
-1,010,519
-
Total reported value, excl. options
-
$1,928,597,642
-
Value change
-
-$45,329,737
-
Number of buys
-
91
-
Number of sells
-
-103
-
Price
-
$43.74
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q1 2021
280 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q1 2021.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,092,800 shares
of 46,382,189 outstanding shares and own 95.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,611,068 shares), VANGUARD GROUP INC (4,484,264 shares), WELLINGTON MANAGEMENT GROUP LLP (3,938,796 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,220,883 shares), Champlain Investment Partners, LLC (2,912,188 shares), Paradice Investment Management LLC (2,466,294 shares), DIMENSIONAL FUND ADVISORS LP (2,269,397 shares), VICTORY CAPITAL MANAGEMENT INC (1,946,985 shares), RGM Capital, LLC (1,921,655 shares), and STATE STREET CORP (1,686,825 shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.